Additionally, the study showed that a diet-switch regimen serves as a selective therapeutic approach, as most NAFLD markers (SREBP-1, PPARγ, and NF-κB) and histological alterations were significantly ameliorated by this intervention [60]. Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.